About ACS Biomarker
ACS Biomarker is a company based in Maastricht (Netherlands) founded in 2007. ACS Biomarker operates in a competitive market with competitors including BioImage, Lodestone Biomedical, BioAmp Diagnostics, HAWK Biosystems and Araceli Biosciences, among others.
- Headquarter Maastricht, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ACS Biomarker
Investors in ACS Biomarker
ACS Biomarker has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Life Sciences Fund Amsterdam and Brightlands Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Brightlands Venture Partners is focused on venture capital investments.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for ACS Biomarker
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ACS Biomarker
Investment portfolio details for ACS Biomarker
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ACS Biomarker
Detailed financials for ACS Biomarker
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acs Biomarker Comparisons
Peer comparison for ACS Biomarker
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ACS Biomarker
ACS Biomarker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioImage, Lodestone Biomedical, BioAmp Diagnostics, HAWK Biosystems and Araceli Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bioassays are developed for biopharmaceutical firms and research organizations.
|
|
| Locked | Locked | Locked |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| Locked | Locked | Locked |
Developers of diagnostic tests that help to treat patient with a specific antibiotic
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| Locked | Locked | Locked |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
Detailed competitors of ACS Biomarker
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acs Biomarker
Complete news archive for ACS Biomarker
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACS Biomarker
ACS Biomarker was founded in 2007 and raised its 1st funding round 4 years after it was founded.
ACS Biomarker is headquartered in Maastricht, Netherlands. It is registered at Maastricht, Limburg, Netherlands.
Heico Breek is the current CEO of ACS Biomarker.
Founded in 2007, ACS Biomarker operates as a biotechnology firm in Maastricht, Netherlands, where biomarkers for cardiac disease are developed to enhance prognosis and management. Discovery and validation processes are emphasized to identify molecular mechanisms underlying disorders, supporting early detection and reducing healthcare costs. Additionally, biomarkers are utilized in drug development to evaluate therapeutic efficacy and safety at initial stages.
ACS Biomarker's top competitors include Araceli Biosciences, Lodestone Biomedical and BioAmp Diagnostics.
ACS Biomarker has 3 investors. Key investors include European Union, Life Sciences Fund Amsterdam, and Brightlands Venture Partners.